Amphastar Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio11.1921.5414.8217.94680.90
Forward P/E9.4220.7716.2916.9623.74
P/S Ratio2.444.602.712.552.73
P/B Ratio2.444.632.562.502.13
Price/Tangible Book12.60113.422.762.742.64
Price/FCF10.3620.3920.7915.8040.81
Price/OCF8.3716.1515.1911.3716.68
PEG Ratio0.990.920.860.890.95
Enterprise Value Ratios
EV/Revenue2.965.182.552.532.77
EV/EBITDA8.3814.039.6311.6527.85
EV/EBIT10.5416.7011.8515.4373.07
EV/FCF12.5622.9519.5515.6841.37
Profitability & Returns
Return on Equity (ROE)0.23%0.24%0.19%0.14%0.00%
Return on Assets (ROA)0.08%0.11%0.10%0.07%0.01%
Return on Invested Capital (ROIC)0.16%0.22%0.20%0.13%0.01%
Return on Capital Employed (ROCE)0.15%0.15%0.17%0.13%0.03%
Leverage & Solvency Ratios
Debt/Equity0.890.970.190.230.15
Debt/EBITDA2.462.560.751.051.69
Debt/FCF3.774.291.571.482.87
Liquidity Ratios
Current Ratio3.072.173.993.062.49
Quick Ratio2.101.652.792.081.53
Efficiency Ratios
Asset Turnover0.470.570.710.670.57
Inventory Turnover2.762.772.552.511.99
Yield & Distribution Ratios
Earnings Yield0.09%0.05%0.07%0.06%0.00%
FCF Yield0.10%0.05%0.05%0.06%0.02%
Buyback Yield0.02%-0.01%-0.05%-0.01%0.02%